Navigation Links
ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
Date:3/3/2009

are; line-height:1.5em; list-style-image: url(/images_v4/bullet_solid2.gif);">
  • Aggregate multiple studies into a program/portfolio view or long-range plan
  • Generate comprehensive monthly budget, resource, and timeline reports
  • Add or remove studies from a portfolio
  • Modify study start dates
  • Adjust study probabilities

  • "ClearTrial Portfolio Planning gives life sciences companies a lightning-fast and more informed portfolio and program decision-making capability that presents a major competitive advantage, especially in today's economic climate," noted Mike Soenen, Managing Partner of ClearTrial. "The pressure to move faster with fewer resources has never been greater and with Portfolio Planning, ClearTrial is again first in class to answer that challenge."

    Key Benefits of ClearTrial Portfolio Planning
    For clinical operations, outsourcing, finance, and project/resource management professionals at life sciences organizations, ClearTrial Portfolio Planning offers:

    Integrated Roll-up for Increased Accuracy and Speed - The software eliminates errors in the time-consuming re-keying involved with manually rolling up multiple study plans into program- or company-wide forecasts. ClearTrial Portfolio Planning also ensures that planners are using the most current information by automatically updating the portfolio forecast with any changes made to the protocol-level assumptions.

    Effortless Cost and Resource Demand Forecasting Across the Organization - Monthly cost and resource demand forecasts enable companies to easily identify areas of heavy FTE utilization, and more proactively hire or contract for additional resources - or modify study start dates to smooth out resource utilization. Planners can instantly see the budget and resource impact of dropping or delaying a study or group of studies, immediately assess the result on hours and fees, by month, of outsourcing al
    '/>"/>

    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
    2. Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimers Disease
    3. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
    4. EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
    5. Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement
    6. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
    7. BioSpace.com Launches a New Season of Industry Career Fairs
    8. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
    9. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
    10. Cephalons New Product Launches Pace Record 2008 Sales
    11. BioComp Pharma Launches First Generic Drug for Tindamax(R)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... Vermillion, Inc. (Nasdaq:   VRML), a ... today that investors including Oracle Investment Management, ... several Vermillion directors have agreed to purchase approximately ... stock and warrants to purchase unregistered shares of ... Under the terms of the private ...
    (Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
    (Date:12/24/2014)... , Dec. 23, 2014  NeuroLifeSciences announced today ... in children with attention deficit/hyperactivity disorder published in ... The paper, titled "Pilot Phase 2 ... ( Konofal et al, Drug Des Devel ... shows that mazindol might be an effective, well-tolerated, ...
    (Date:12/22/2014)... 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, with ... announced positive topline safety and tolerability results ... SYN-004, the Company,s investigational oral beta-lactamase enzyme ... (C. difficile) infection, antibiotic-associated diarrhea and ...
    Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
    ... 16 Regado Biosciences, a privately held company leading ... announced that David J. Mazzo, PhD, President and CEO, ... Conference.  Dr. Mazzo,s presentation will be given at the ... September 22, 2010 at 8:00 a.m. EDT in Ballroom ...
    ... DENVER, Sept. 16 BioSpace and BioMed ... BioMed Central Career Network today, ... professionals seeking quality recruitment, job opportunities and ... ) (Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO ) ...
    ... (NYSE: CRY ), an implantable biological medical device ... participate in the UBS Global Life Sciences Conference at The ... Ashley Lee, executive vice president, chief operating officer and chief ... on Tuesday, September 21, 2010 at 3:30 p.m., Eastern Time. ...
    Cached Biology Technology:Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City 2Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City 3BioSpace and BioMed Central Create Global Career Community 2CryoLife to Present at UBS Global Life Sciences Conference 2
    (Date:12/19/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ... Market Monitor: North America Perimeter Security Systems Market" ... http://photos.prnewswire.com/prnh/20130307/600769 The North American perimeter security ... 3.6% from 2014 to 2019. Although the U.S. market ... Canada is expected to grow at a ...
    (Date:12/17/2014)... 2014  HITLAB SM announced today its ... to confirm its adherence to current U.S. Food ... HITLAB to conduct regulated smart device and smart ... patient safety and research quality. "HITLAB ... and delivery with innovative technology," said Laura ...
    (Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
    Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
    ... (NTU) and Temasek Foundation are working together to ... People,s Republic of China which are prone to ... seismic-resistant construction technologies, the programme aims to promote ... enhance the skills of those involved in China ...
    ... -- Researchers at Burnham Institute for Medical Research ... University of Maryland have demonstrated that an enzyme ... targeted to kill dangerous pathogens. In addition, investigators ... and suppress the growth of pathogenic bacteria. These ...
    ... University has succeeded in extracting long DNA fragments from ... Linnaeus, apprentice Adam Afzelius. It is hoped that the ... light on whether plants growing today at Linnaeus, Hammarby ... himself. A large number of plants of uncertain ...
    Cached Biology News:NTU and Temasek Foundation transfer technology knowhow to China's quake-prone regions 2NTU and Temasek Foundation transfer technology knowhow to China's quake-prone regions 3The path to new antibiotics 2
    ... General description: Designed for use with ... CLS number is a new product number, ... If showing no availability yet, please order ... contact customer service for assistance. Comp Dim: ...
    ... G bind specifically to Fc regions of ... G conjugates are commonly used as affinity ... subtypes from serum, hybridoma ascites fluids, tissue ... reagents are also commonly used to capture ...
    ... Stem Cell Identification Kit. ... a substrate for the ... that is highly expressed ... cells, making ALDH an ...
    ... LED produces output at 470 nm; includes interface ... S2000 or installed into rack or desktop boxes ... Source is an LED that produces either pulsed ... blue region -- for fluorescence measurements. The source ...
    Biology Products: